Hostname: page-component-74656f9884-8r8nv Total loading time: 0 Render date: 2026-11-07T01:33:52.924Z Has data issue: false hasContentIssue false

Nitric oxide production and the expression of two nitric oxide synthases in the avian retina

Published online by Cambridge University Press:  30 May 2013

MERVE TEKMEN-CLARK*
Affiliation:
Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana
EVANNA GLEASON*
Affiliation:
Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana
*
Address correspondence to: Evanna Gleason, Department of Biological Sciences, Louisiana State University, 202 Life Sciences Building, Baton Rouge, LA 70803. E-mail: egleaso@lsu.edu
Rights & Permissions [Opens in a new window]

Abstract

Nitric oxide (NO) is known to exert multiple effects on the function of many retinal neurons and their synapses. Therefore, it is equally important to understand the potential sources of NO within the retina. To explore this, we employ a combination of 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM) based NO detection and immunohistochemistry for the NO synthetic enzymes, neuronal and endothelial nitric oxide synthase (nNOS and eNOS). We find DAF signals in photoreceptors, horizontal cells, amacrine cells, efferent synapses, Müller cells, and cells in the ganglion cell layer (GCL). nNOS immunoreactivity was consistent with the DAF signal with the exception that horizontal cells and Müller cells were not clearly labeled. eNOS-like immunoreactivity (eNOS-LI) was more widespread with photoreceptors, horizontal cells, occasional bipolar cells, amacrine cells, Müller cells, and cells in the GCL all showing labeling. Double labeling with antibodies raised against calretinin, syntaxin, and glutamine synthetase confirmed that horizontal cells, amacrine cells, and Müller cells (respectively) were expressing eNOS-LI. Although little or no nNOS labeling is observed in horizontal cells or Müller cells, the expression of eNOS-LI is consistent with the ability of these cells to produce NO. Together these results suggest that the capability to produce NO is widespread in the chicken retina. We propose that multiple forms of regulation for nNOS and eNOS play a role in the patterning of NO production in the chicken retina.

Information

Type
Research Articles
Copyright
Copyright © Cambridge University Press 2013 
Figure 0

Fig. 1. NO production in the chicken retina. (A–G) Images of DAF-FM-loaded and fixed retinal sections from the ventral retina. All samples (except in E) were prepared in solutions containing 250 µM NMDA. (A) Arrowheads indicate DAF-FM-positive horizontal cells and arrows denote likely amacrine cells. One cell has a strong signal in the GCL. Asterisks indicate prominent labeled processes in the nerve fiber layer that may be efferent fibers originating from the ION of the brain. The section in (B) has few horizontal cells labeled as compared to that in (A). This section (B) contains a labeled efferent synapse (arrowhead) and labeled nontarget amacrine cells (arrow). The asterisk indicates a thick process crossing the IPL and is likely to be originating from the ION. A few cells are labeled in the GCL. (C) Another retinal section has strong horizontal cell signal as well as numerous cell bodies with DAF signal in the INL. Arrows indicate nontarget amacrine cells and the arrowheads denote efferent synapses. (D) A section is shown from the same retina as (C) but processed with the NMDA receptor blocker APV (250 µM) in the incubation solution. Under these conditions, the horizontal cell signal persists but the DAF signal in the INL has been suppressed. (E) A section from a retina that was DAF-loaded and incubated in the absence of NMDA. (F) This section from another retina shows a strong horizontal cell DAF signal and a strong signal in two efferent synapses (arrow). This section is at a slight angle such that horizontal cell bodies and processes are especially prominent. The asterisk indicates the process that runs across the IPL leading to the synapse on the right. The section in (G) is from the same retina as (F) but processed in the presence of the NOS inhibitor L-NG-nitroarginine methyl ester (L-NAME) (200 µM) and shows that with inhibition of NOS activity, the DAF signal is strongly suppressed. Scale bar is 50 µm (A–E), 30 µm (F and G).

Figure 1

Table 1. Antibodies used in this study

Figure 2

Fig. 2. The pattern of the DAF-FM signal can be altered in different buffering conditions. (A) An example of a section of a DAF-FM-loaded retina processed in normal external solution containing 10 mM HEPES. (B) A section from the same DAF-FM-loaded retina as in (A) but was processed in bicarbonate-buffered external solution shows extensive DAF-FM signal in Müller glial cells. Scale bar in (A) is 50 µm and applies to (B) as well. (C and D) Examples of “hot spots” of DAF-FM signal occasionally observed in sections of retina processed in normal (HEPES-buffered) external solution. In both cases, a group of horizontal cells have relatively strong DAF-FM signal and the signal is also observed in the Müller cells in the same location. Scale bar in (C) is 50 µm and also applies to (D).

Figure 3

Fig. 3. The specificity of the eNOS antibody in chicken tissue. (A) Western blot of protein (300 µg/lane) from CB and MBs. The eNOS antibody detects protein near the appropriate molecular weight for eNOS (135 kDa) in both MB and CB. The additional band in CB may represent a degradation product. (B) A section of chicken retina labeled with the eNOS antibody. (C) Preincubation of the primary antibody with the antigen peptide markedly reduces eNOS antibody labeling. (D and E) A section of a DAF-FM-loaded retina is also treated with the secondary antibody used to visualize eNOS. No interference from the DAF-FM signal and no nonspecific labeling are seen in the secondary only control. Scale bar is 50 µm.

Figure 4

Fig. 4. NOS-expressing cells and nitric oxide (NO) production. (A–C) Confocal microscopy images of DAF-FM-labeling along with anti-nNOS. Efferent synapses are both DAF-FM- and neuronal NOS-positive (arrows), and anti-nNOS also labels target cell somata (B). Arrowheads indicate processes at the outer border of the IPL that are co-labeled with DAF-FM and anti-nNOS. Asterisks indicate nNOS-positive nontarget amacrine cells. (D–F) Confocal images of DAF-FM labeling along with anti-eNOS. Vertical arrows indicate DAF-FM- and anti-eNOS-positive horizontal cells. Diagonal arrow shows an efferent synapse positive for anti-eNOS and DAF-FM. Arrowheads in (E) indicate a band of eNOS-LI near the border of IPL and GCL that is often observed. Scale bar is 50 µm.

Figure 5

Fig. 5. Neuronal nitric oxide synthase (nNOS) has a different labeling pattern in dorsal and ventral retina. Confocal images of dorsal and ventral retina labeled with the polyclonal nNOS antibodies (A) and (B). The IPL synaptic bands labeled with nNOS are visible both in ventral and dorsal retina. Cells in the GCL are labeled with anti-nNOS both in dorsal and ventral retina; however, more cells are labeled in dorsal retina. There is a weak signal in the OPL and photoreceptor labeling in both dorsal and ventral retina. Dorsal retina contains amacrine cells that have smaller somata than those found in ventral retina (arrows in A). Target amacrine cells and their efferent synapses are confined to the ventral retina (arrows). The ventral retina also contains labeled nontarget amacrine cells with somata larger than those nontarget amacrine cells in dorsal retina (B, arrowheads). (C and D) The pattern of endothelial nitric oxide synthase-like immunoreactivity (eNOS-LI) does not differ in dorsal and ventral retina. Scale bars are 50 µm.

Figure 6

Fig. 6. Identification of retinal cells expressing endothelial nitric oxide synthase-like immunoreactivity (eNOS-LI). (A–F) Images of anti-calretinin and anti-eNOS double-labeling. Some horizontal cell somata (arrowheads) and processes (arrows) were co-labeled with both antibodies (C) and (F). (G–I) Images of sections labeled with HPC-1 (G) and eNOS (H) antibodies and the merged image (I) indicate the co-labeled amacrine cells in the INL (arrows). Arrowheads (G and I) indicate HPC-1 label in the OPL. Boxed region in INL is shown in the inset. (J–O) Sections are labeled with anti-protein kinase C (anti-PKC) (J) anti-eNOS (K) and the merge of both (L). The arrowhead (inset, J–L) shows one bipolar cell body labeled with both antibodies. Boxed region in the INL is shown in the inset. Vertical arrows in (M–O) indicate a band at the border of IPL and GCL labeled with both antibodies. (P–U) Images of a retinal section with GS and eNOS antibody labeling. (S–U) Arrowheads indicate glia labeled with both antibodies. Some double-labeled elements are observed in the GCL. (A–C), (J–O), and (P–U) are derived from ventral retina and (G–I) are derived from dorsal retina. No differences in the labeling pattern for these antibodies were observed between dorsal and ventral retinas. Confocal settings and image adjustments were the same for all eNOS images. Scale bars are 50 µm (A–C, G–I, J-L, and P–R), and 20 µm (insets, D–F, M–O, and S–U).